Home/Filings/4/0001493152-24-049503
4//SEC Filing

Aminov Erez 4

Accession 0001493152-24-049503

CIK 0001904286other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:15 PM ET

Size

9.3 KB

Accession

0001493152-24-049503

Insider Transaction Report

Form 4
Period: 2024-12-09
Aminov Erez
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options (right to buy)

    2024-12-09+2,000,0002,000,000 total
    Exercise: $1.19Exp: 2034-12-09Common Stock (2,000,000 underlying)
  • Award

    Restricted Stock Units

    2024-12-09+500,000500,000 total
    Exp: 2034-12-09Common Stock (500,000 underlying)
Footnotes (6)
  • [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.
  • [F2]The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date.
  • [F3]Represents 2,000,000 stock options that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
  • [F5]The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date.
  • [F6]Represents 500,000 RSUs that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date.

Documents

1 file

Issuer

MIRA PHARMACEUTICALS, INC.

CIK 0001904286

Entity typeother

Related Parties

1
  • filerCIK 0001986112

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:15 PM ET
Size
9.3 KB